Monday Jan 23, 2023

Swapping to edoxaban, DOACs in renal impairment, inflammatory rheumatic diseases in pregnancy

In this podcast, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the February 2023 issue of DTB. They discuss concerns over a national initiative in England to transfer people with atrial fibrillation to edoxaban from other DOACs ( They review a study that examined whether the correct dose of DOAC was used in people with renal impairment ( They talk about the use of empagliflozin in people with heart failure ( and finish with an overview of an article that discusses prescribing for pregnancy for those with inflammatory rheumatic disease ( 60th anniversary interview with Dr John Dowden: Trends in direct oral anticoagulant (DOAC) prescribing in English primary care (2014–2019): The contact address for the DTB team is

Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page ( Thank you for listening.

Copyright 2023 All rights reserved.

Version: 20240320